Anastasis Biotec

Develops mutation-targeted cancer therapies for patients with tumours carrying specific cancer-driving mutations

London, United KingdomFounded 2016anastasisbiotec.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-15

About Anastasis Biotec

Anastasis Biotec is developing proprietary cancer treatments that target specific mutations and pathways. Its approach involves analysing tumour tissue, selecting patients with relevant mutations and treating them with matching pathway inhibitors.

The company is a preclinical-stage oncology biotech developing drug compounds and raising equity to fund preclinical and clinical proof-of-concept trials. It has secured funding from The Christos Lazari Foundation and raised funds through Crowdcube.

ANASTASIS BIOTEC LIMITED was founded in 2016 and is headquartered in London. Its website reports research support at the University of Chicago and a planned cancer conference in Cyprus.

Product: Proprietary pathway inhibitors and mutation-targeted cancer therapies in development.

Jobs at Anastasis Biotec

No open positions listed right now.

More biotech & pharma companies

  • Androlabs

    Commercialises prescription therapies for men's health, including testosterone replacement and erectile dysfunction treatments
    London, United KingdomBiotech & pharmaFounded 20214 open jobs
    Remote-friendlySalary transparent
  • Animalcare

    Animal health medicines and healthcare products for veterinary professionals in the UK
    York, United KingdomBiotech & pharmaFounded 1980
    New on Evolc
  • Antigenika

    Developing an oral, broad-spectrum snakebite treatment for people in regions with limited access to hospital antivenom
    Stokenchurch, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc
  • Antimicrobial Focus

    Consultancy for biotech and pharma firms developing new antimicrobial agents: microbiology, susceptibility testing, development plans
    Sawbridgeworth, United KingdomBiotech & pharmaFounded 2022
    Young companyNew on Evolc
  • Antiverse

    AI-guided antibody discovery and laboratory validation for pharmaceutical and biotech partners targeting GPCRs
    Cardiff, United KingdomBiotech & pharmaFounded 2017
    New on Evolc
  • Apconix

    Nonclinical drug-safety consultancy and ion-channel screening for biotech, biopharma, academic and pharmaceutical R&D teams
    Alderley Edge, United KingdomBiotech & pharmaFounded 2014

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

  • CloudflareHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

  • ApacheHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.